Mujahid A. Rizvi, MD practices Oncology. He studied medicine at Aga Khan Medical College. He has 4 awards "Resident Teaching Award", "Honors in Primary Health Care", "CMS Meaningful Use Stage 1 Certification" and "Fellow American college of physicians". Mujahid A. Rizvi is a published MD as well. He has 5 publications published. The latest was: Enzastaurin (LY317615), a protein kinase Cbeta inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines. He is registered with Medicare.
|
Dr. Dawn Lemanne, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brett A. Poisson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susan E. Kohler, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sandra J. Taylor, MD
|
|
Dr. Jay H. Beckstead, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Xiaoyi N. Hu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sean T. Hehn, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Charles R. Dibb, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard K. Karchmer, MD
|
|
Dr. Aleksandra S. Sander, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Stephen B. Strum, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Erin M. Nelli, DO
This Doctor is OpenDoctor Recommended.
|